Viewing Study NCT04323761


Ignite Creation Date: 2025-12-24 @ 12:13 PM
Ignite Modification Date: 2026-01-03 @ 6:34 PM
Study NCT ID: NCT04323761
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2020-11-13
First Post: 2020-03-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module